Amarin Corporation plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMRN Nasdaq 2836 www.amarincorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amarin Corporation plc

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday - May 28th, 2026 9:14 am
Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) - May 27th, 2026 9:24 am
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia - May 27th, 2026 6:00 am
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading - May 26th, 2026 9:09 am
How The Amarin (AMRN) Story Is Shifting With A Refined Fair Value And Outlook - May 21st, 2026 8:16 pm
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading - May 18th, 2026 9:11 am
Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year - May 15th, 2026 10:08 am
CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised - May 15th, 2026 8:11 am
European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading - May 14th, 2026 9:05 am
ESPR Stock Surges 44% in a Month: Here's What You Need to Know - May 14th, 2026 8:44 am
Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil - May 14th, 2026 8:42 am
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1 - May 14th, 2026 8:17 am
Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease - May 13th, 2026 9:21 am
NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus - May 12th, 2026 9:44 am
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - May 12th, 2026 9:18 am
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus - May 11th, 2026 9:50 am
BDTX Shares Gain 11% in a Week: Here's What You Should Know - May 11th, 2026 9:48 am
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised - May 11th, 2026 9:27 am
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading - May 11th, 2026 9:05 am
TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle - May 8th, 2026 11:26 am